SBI Life Insurance Company Share Price
1826.50+0.00 (+1.21%)
-9.69% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
LICINSE
SBILIFENSE
HDFCLIFENSE
ICICIGINSE
ICICILIFENSE
GICRENSE
STARHEALTHNSE
NIACLNSE
GODIGITNSE
NIVABUPANSE
SBI Life Insurance Company Share Price
1826.50+0.00 (+1.21%)
-9.69% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 19% |
| - | - | - | 2% |
| - | 9% | 9% | -10% |
| 16% | 14% | 14% | 14% |
Peer Comparison
Symbol
LICI
SBILIFE
HDFCLIFE
ICICIGI
ICICILIFE
GICRE
STARHEALTH
NIACL
GODIGIT
NIVABUPA
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 405.1 | ₹511186 Cr | 8.23 | 9.58 | 49.09 | ₹0 |
| 1,811.8 | ₹180621 Cr | 68.02 | 5.47 | 26.46 | ₹0 |
| 577.55 | ₹125366 Cr | 61.2 | 2.4 | 9.43 | ₹0 |
| 1,703.3 | ₹84210 Cr | 32.96 | 18.94 | 51.12 | ₹0 |
| 459.5 | ₹66214 Cr | — | 4.31 | — | ₹0 |
| 337.8 | ₹59316 Cr | 6.61 | 16.9 | 51.12 | ₹0 |
| 559.15 | ₹33440 Cr | 31.72 | 4.5 | 17.91 | ₹0 |
| 151.51 | ₹25272 Cr | — | -7.59 | -3.25 | ₹0 |
| 240.55 | ₹22402 Cr | 43.22 | 1.54 | 5.6 | ₹0 |
| 73.81 | ₹13691 Cr | 25.79 | 0.73 | 2.87 | ₹0 |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
PBT
Net Profit
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | Dec 2018 | Sep 2018 | Jun 2018 | Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 | Dec 2016 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹26878 Cr | ₹20078 Cr | ₹27684 Cr | ₹30245 Cr | ₹24848 Cr | ₹17179 Cr | ₹23861 Cr | ₹24828 Cr | ₹20266 Cr | ₹15106 Cr | ₹25117 Cr | ₹22317 Cr | ₹20050 Cr | ₹13105 Cr | ₹19897 Cr | ₹19171 Cr | ₹16477 Cr | ₹11036 Cr | ₹17434 Cr | ₹18025 Cr | ₹14661 Cr | ₹8313 Cr | ₹15556 Cr | ₹13767 Cr | ₹12858 Cr | ₹7588 Cr | ₹11863 Cr | ₹11695 Cr | ₹10112 Cr | ₹6655 Cr | ₹11333 Cr | ₹9141 Cr | ₹7662 Cr | ₹4755 Cr | ₹9237 Cr | ₹6776 Cr | ₹5385 Cr | ₹3763 Cr | ₹7346 Cr | ₹5243 Cr | ₹4921 Cr |
| -₹2230 Cr | ₹26294 Cr | -₹21700 Cr | ₹15914 Cr | -₹1717 Cr | ₹21810 Cr | ₹560 Cr | -₹5968 Cr | ₹20032 Cr | ₹19552 Cr | ₹12778 Cr | ₹16734 Cr | ₹8767 Cr | ₹14800 Cr | ₹3121 Cr | ₹7659 Cr | ₹11251 Cr | -₹6219 Cr | ₹4232 Cr | ₹2656 Cr | ₹10986 Cr | ₹7709 Cr | ₹4745 Cr | ₹12962 Cr | ₹203 Cr | ₹8686 Cr | -₹6674 Cr | ₹4260 Cr | ₹155 Cr | ₹3161 Cr | ₹4308 Cr | ₹3144 Cr | ₹2100 Cr | ₹2239 Cr | ₹857 Cr | ₹2931 Cr | ₹2465 Cr | ₹2736 Cr | ₹3458 Cr | ₹819 Cr | ₹2931 Cr |
| ₹24648 Cr | ₹46372 Cr | ₹5984 Cr | ₹46159 Cr | ₹23132 Cr | ₹38989 Cr | ₹24421 Cr | ₹18859 Cr | ₹40298 Cr | ₹34657 Cr | ₹37895 Cr | ₹39051 Cr | ₹28816 Cr | ₹27904 Cr | ₹23018 Cr | ₹26830 Cr | ₹27729 Cr | ₹4817 Cr | ₹21666 Cr | ₹20682 Cr | ₹25646 Cr | ₹16022 Cr | ₹20301 Cr | ₹26728 Cr | ₹13061 Cr | ₹16275 Cr | ₹5189 Cr | ₹15955 Cr | ₹10266 Cr | ₹9816 Cr | ₹15641 Cr | ₹12285 Cr | ₹9761 Cr | ₹6993 Cr | ₹10093 Cr | ₹9707 Cr | ₹7850 Cr | ₹6499 Cr | ₹10804 Cr | ₹6062 Cr | ₹7852 Cr |
| ₹24058 Cr | ₹45579 Cr | ₹5117 Cr | ₹45517 Cr | ₹22600 Cr | ₹38333 Cr | ₹23520 Cr | ₹18266 Cr | ₹39696 Cr | ₹34060 Cr | ₹37043 Cr | ₹38681 Cr | ₹28392 Cr | ₹27471 Cr | ₹22197 Cr | ₹26483 Cr | ₹27292 Cr | ₹4516 Cr | ₹20941 Cr | ₹20272 Cr | ₹25364 Cr | ₹15752 Cr | ₹19799 Cr | ₹26432 Cr | ₹12762 Cr | ₹15648 Cr | ₹4602 Cr | ₹15486 Cr | ₹10147 Cr | ₹9439 Cr | ₹15130 Cr | ₹11969 Cr | ₹9466 Cr | ₹6475 Cr | ₹9652 Cr | ₹9439 Cr | ₹7580 Cr | ₹6055 Cr | ₹10443 Cr | ₹5843 Cr | ₹7592 Cr |
| ₹590 Cr | ₹793 Cr | ₹867 Cr | ₹642 Cr | ₹532 Cr | ₹656 Cr | ₹901 Cr | ₹594 Cr | ₹601 Cr | ₹597 Cr | ₹851 Cr | ₹370 Cr | ₹424 Cr | ₹433 Cr | ₹822 Cr | ₹346 Cr | ₹437 Cr | ₹301 Cr | ₹725 Cr | ₹410 Cr | ₹283 Cr | ₹270 Cr | ₹502 Cr | ₹296 Cr | ₹300 Cr | ₹627 Cr | ₹587 Cr | ₹469 Cr | ₹119 Cr | ₹378 Cr | ₹511 Cr | ₹317 Cr | ₹295 Cr | ₹518 Cr | ₹442 Cr | ₹268 Cr | ₹269 Cr | ₹444 Cr | ₹361 Cr | ₹220 Cr | ₹260 Cr |
| ₹590 Cr | ₹793 Cr | ₹867 Cr | ₹642 Cr | ₹532 Cr | ₹656 Cr | ₹901 Cr | ₹594 Cr | ₹601 Cr | ₹597 Cr | ₹851 Cr | ₹370 Cr | ₹424 Cr | ₹433 Cr | ₹822 Cr | ₹346 Cr | ₹437 Cr | ₹301 Cr | ₹725 Cr | ₹410 Cr | ₹283 Cr | ₹270 Cr | ₹502 Cr | ₹296 Cr | ₹300 Cr | ₹627 Cr | ₹587 Cr | ₹469 Cr | ₹119 Cr | ₹378 Cr | ₹511 Cr | ₹317 Cr | ₹295 Cr | ₹518 Cr | ₹442 Cr | ₹268 Cr | ₹269 Cr | ₹444 Cr | ₹361 Cr | ₹220 Cr | ₹260 Cr |
| ₹549 Cr | ₹725 Cr | ₹805 Cr | ₹577 Cr | ₹495 Cr | ₹594 Cr | ₹814 Cr | ₹551 Cr | ₹529 Cr | ₹520 Cr | ₹811 Cr | ₹322 Cr | ₹380 Cr | ₹381 Cr | ₹777 Cr | ₹304 Cr | ₹377 Cr | ₹263 Cr | ₹672 Cr | ₹364 Cr | ₹247 Cr | ₹223 Cr | ₹532 Cr | ₹233 Cr | ₹300 Cr | ₹391 Cr | ₹531 Cr | ₹390 Cr | ₹130 Cr | ₹372 Cr | ₹458 Cr | ₹264 Cr | ₹251 Cr | ₹354 Cr | ₹381 Cr | ₹230 Cr | ₹225 Cr | ₹313 Cr | ₹336 Cr | ₹190 Cr | ₹213 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Shareholder's Funds
Current Liabilities
Other Current Liabilities
Short Term Provisions
Total Liabilities
Contingent Liabilities
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Total Non-Current Assets
Current Assets Loans & Advances
Cash and Bank
Other Current Assets
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹1003 Cr | ₹1002 Cr | ₹1001 Cr | ₹1001 Cr | ₹1000 Cr | ₹1000 Cr | ₹1000 Cr | ₹1000 Cr | ₹1000 Cr | ₹1000 Cr | ₹1000 Cr | ₹1000 Cr | ₹1000 Cr | ₹1000 Cr | ₹1000 Cr | ₹1000 Cr | ₹1000 Cr | ₹1000 Cr |
| ₹7 Cr | ₹5 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹42 L | ₹11 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹18077 Cr | ₹15786 Cr | ₹13588 Cr | ₹11922 Cr | ₹10417 Cr | ₹9092 Cr | ₹7884 Cr | ₹6460 Cr | ₹5374 Cr | ₹4465 Cr | ₹3691 Cr | ₹2974 Cr | ₹2306 Cr | ₹1683 Cr | ₹1119 Cr | ₹621 Cr | ₹255 Cr | -₹22 Cr |
| ₹19087 Cr | ₹16793 Cr | ₹14592 Cr | ₹12925 Cr | ₹11418 Cr | ₹10093 Cr | ₹8884 Cr | ₹7460 Cr | ₹6374 Cr | ₹5465 Cr | ₹4691 Cr | ₹0 | ₹0 | ₹0 | ₹2119 Cr | ₹1621 Cr | ₹1255 Cr | ₹978 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹7508 Cr | ₹5791 Cr | ₹5195 Cr | ₹4644 Cr | ₹4559 Cr | ₹3805 Cr | ₹2784 Cr | ₹3377 Cr | ₹3216 Cr | ₹2764 Cr | ₹2503 Cr | ₹0 | ₹0 | ₹0 | ₹1254 Cr | ₹1707 Cr | ₹1430 Cr | ₹1007 Cr |
| ₹3262 Cr | ₹2883 Cr | ₹2578 Cr | ₹2391 Cr | ₹2366 Cr | ₹2232 Cr | ₹1809 Cr | ₹1617 Cr | ₹1293 Cr | ₹982 Cr | ₹734 Cr | ₹558 Cr | ₹381 Cr | ₹228 Cr | ₹166 Cr | ₹63 Cr | ₹32 Cr | ₹26 Cr |
| ₹492053 Cr | ₹450923 Cr | ₹392783 Cr | ₹309587 Cr | ₹268207 Cr | ₹222592 Cr | ₹162558 Cr | ₹142998 Cr | ₹118156 Cr | ₹99225 Cr | ₹80725 Cr | ₹0 | ₹0 | ₹0 | ₹46917 Cr | ₹39526 Cr | ₹28143 Cr | ₹14003 Cr |
| ₹605 Cr | ₹1212 Cr | ₹1340 Cr | ₹1077 Cr | ₹1111 Cr | ₹1644 Cr | ₹1115 Cr | ₹1133 Cr | ₹549 Cr | ₹410 Cr | ₹467 Cr | ₹481 Cr | ₹445 Cr | ₹340 Cr | ₹136 Cr | ₹100 Cr | ₹58 Cr | ₹0 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹1490 Cr | ₹1347 Cr | ₹1265 Cr | ₹1237 Cr | ₹1193 Cr | ₹1179 Cr | ₹1094 Cr | ₹1003 Cr | ₹862 Cr | ₹807 Cr | ₹564 Cr | ₹521 Cr | ₹503 Cr | ₹452 Cr | ₹431 Cr | ₹414 Cr | ₹158 Cr | ₹141 Cr |
| ₹843 Cr | ₹767 Cr | ₹713 Cr | ₹716 Cr | ₹669 Cr | ₹615 Cr | ₹526 Cr | ₹440 Cr | ₹351 Cr | ₹300 Cr | ₹263 Cr | ₹256 Cr | ₹221 Cr | ₹179 Cr | ₹167 Cr | ₹134 Cr | ₹108 Cr | ₹78 Cr |
| ₹647 Cr | ₹580 Cr | ₹551 Cr | ₹520 Cr | ₹524 Cr | ₹564 Cr | ₹568 Cr | ₹563 Cr | ₹511 Cr | ₹507 Cr | ₹301 Cr | ₹265 Cr | ₹282 Cr | ₹273 Cr | ₹263 Cr | ₹280 Cr | ₹50 Cr | ₹63 Cr |
| ₹41 Cr | ₹10 Cr | ₹6 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr | ₹13 Cr | ₹32 Cr | ₹70 Cr | ₹31 Cr | ₹146 Cr | ₹0 | ₹0 | ₹0 | ₹2 Cr | ₹3 Cr | ₹183 Cr | ₹7 Cr |
| ₹688 Cr | ₹590 Cr | ₹557 Cr | ₹522 Cr | ₹527 Cr | ₹565 Cr | ₹581 Cr | ₹595 Cr | ₹581 Cr | ₹538 Cr | ₹447 Cr | ₹0 | ₹0 | ₹0 | ₹265 Cr | ₹283 Cr | ₹233 Cr | ₹70 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹3208 Cr | ₹1847 Cr | ₹4746 Cr | ₹4165 Cr | ₹3204 Cr | ₹2711 Cr | ₹1423 Cr | ₹2421 Cr | ₹2645 Cr | ₹2430 Cr | ₹2617 Cr | ₹2524 Cr | ₹2542 Cr | ₹2153 Cr | ₹2303 Cr | ₹803 Cr | ₹322 Cr | ₹128 Cr |
| ₹8834 Cr | ₹6288 Cr | ₹6680 Cr | ₹5098 Cr | ₹4336 Cr | ₹4382 Cr | ₹4345 Cr | ₹4176 Cr | ₹3846 Cr | ₹3231 Cr | ₹2372 Cr | ₹0 | ₹0 | ₹0 | ₹858 Cr | ₹509 Cr | ₹315 Cr | ₹243 Cr |
| ₹492053 Cr | ₹450923 Cr | ₹392783 Cr | ₹309587 Cr | ₹268207 Cr | ₹222592 Cr | ₹162558 Cr | ₹142998 Cr | ₹118156 Cr | ₹99225 Cr | ₹80725 Cr | ₹0 | ₹0 | ₹0 | ₹46917 Cr | ₹39526 Cr | ₹28143 Cr | ₹14003 Cr |
| ₹190 | ₹168 | ₹146 | ₹129 | ₹114 | ₹101 | ₹89 | ₹75 | ₹64 | ₹55 | ₹47 | ₹40 | ₹33 | ₹27 | ₹21 | ₹16 | ₹13 | ₹10 |
| ₹190 | ₹168 | ₹146 | ₹129 | ₹114 | ₹101 | ₹89 | ₹75 | ₹64 | ₹55 | ₹47 | ₹40 | ₹33 | ₹27 | ₹21 | ₹16 | ₹13 | ₹10 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹36931 Cr | ₹28365 Cr | ₹31559 Cr | ₹30846 Cr | ₹23836 Cr | ₹25556 Cr | ₹20891 Cr | ₹14871 Cr | ₹11384 Cr | ₹9450 Cr | ₹7352 Cr | ₹3314 Cr | ₹663 Cr | ₹1467 Cr | ₹6600 Cr | ₹8789 Cr | ₹8048 Cr | ₹6298 Cr |
| -₹17 Cr | -₹13 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹36914 Cr | ₹28352 Cr | ₹31559 Cr | ₹30846 Cr | ₹23836 Cr | ₹25556 Cr | ₹20891 Cr | ₹14871 Cr | ₹11384 Cr | ₹9450 Cr | ₹7352 Cr | ₹3314 Cr | ₹663 Cr | ₹1467 Cr | ₹6600 Cr | ₹8789 Cr | ₹8048 Cr | ₹6298 Cr |
| ₹34523 Cr | ₹25547 Cr | ₹29122 Cr | ₹28656 Cr | ₹21852 Cr | ₹23878 Cr | ₹19299 Cr | ₹13473 Cr | ₹10395 Cr | ₹8525 Cr | ₹5778 Cr | ₹2715 Cr | ₹168 Cr | ₹1130 Cr | ₹6468 Cr | ₹8606 Cr | ₹7842 Cr | ₹6145 Cr |
| -₹35318 Cr | -₹21789 Cr | -₹31221 Cr | -₹30203 Cr | -₹21611 Cr | -₹19203 Cr | -₹16987 Cr | -₹13553 Cr | -₹8910 Cr | -₹9031 Cr | -₹7204 Cr | -₹182 Cr | -₹710 Cr | -₹1222 Cr | -₹4968 Cr | -₹8663 Cr | -₹7915 Cr | -₹6205 Cr |
| -₹179 Cr | -₹215 Cr | -₹227 Cr | -₹415 Cr | -₹231 Cr | ₹3 Cr | -₹198 Cr | -₹241 Cr | -₹221 Cr | -₹144 Cr | -₹144 Cr | -₹117 Cr | -₹58 Cr | -₹58 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| -₹974 Cr | ₹3543 Cr | -₹2327 Cr | -₹1962 Cr | ₹10 Cr | ₹4678 Cr | ₹2113 Cr | -₹321 Cr | ₹1264 Cr | -₹651 Cr | -₹1570 Cr | ₹2416 Cr | -₹600 Cr | -₹150 Cr | ₹1500 Cr | -₹56 Cr | -₹73 Cr | -₹59 Cr |
| ₹10139 Cr | ₹6596 Cr | ₹8923 Cr | ₹10885 Cr | ₹10875 Cr | ₹6198 Cr | ₹4084 Cr | ₹4405 Cr | ₹3141 Cr | ₹3808 Cr | ₹5378 Cr | ₹2962 Cr | ₹3562 Cr | ₹2303 Cr | ₹803 Cr | ₹322 Cr | ₹395 Cr | ₹454 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹59 L | ₹51 L | ₹46 L | ₹15 L | -₹52 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹9165 Cr | ₹10139 Cr | ₹6596 Cr | ₹8923 Cr | ₹10885 Cr | ₹10875 Cr | ₹6198 Cr | ₹4084 Cr | ₹4405 Cr | ₹3157 Cr | ₹3808 Cr | ₹5378 Cr | ₹2962 Cr | ₹2153 Cr | ₹2303 Cr | ₹266 Cr | ₹322 Cr | ₹395 Cr |
Fundamental Ratios
Consolidated
Standalone

No results found
SBI Life Insurance Company Share Price
1826.50+0.00 (+1.21%)
-9.69% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 5
Bearish signals: 3 out of 9 oscillators
RSI
63.48Buy
STOCH %K
95.56Sell
MACD Level(12,26)
33.23Buy
Ultimate Oscillator
68.77Buy
Aroon Oscillator
34.00Sell
BOP
0.72Buy
CCI
89.39Neutral
Williams %R
-4.44Sell
Momentum
166.00Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 8
Bearish signals: 1 out of 9 moving averages
EMA 9
1794.28Buy
SMA 9
1798.47Buy
EMA 21
1757.77Buy
SMA 21
1734.15Buy
EMA 50
1740.13Buy
SMA 50
1716.55Buy
EMA 200
1795.14Buy
SMA 200
1827.59Sell
WMA 20
1773.65Buy
Pivot
Pivot
Classic
Resistance 5
1967.90
Resistance 4
1925.20
Resistance 3
1882.50
Resistance 2
1839.80
Resistance 1
1822.20
Pivot
1797.10
Support 1
1779.50
Support 2
1754.40
Support 3
1711.70
Support 4
1669.00
Support 5
1626.30
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
SBI Life Insurance Company Share Price
1826.50+0.00 (+1.21%)
-9.69% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 55.31% | 55.32% | 55.33% | 55.34% | 55.36% | 55.37% |
| 20.68% | 20.95% | 21.51% | 21.88% | 21.84% | 22.34% |
| 4.28% | 3.80% | 3.86% | 3.71% | 3.68% | 3.61% |
| 15.77% | 15.87% | 15.27% | 15.01% | 15.02% | 14.63% |
| 3.96% | 4.06% | 4.03% | 4.06% | 4.10% | 4.05% |
Bulk & block deals
Name
Pioneer Investment Fund Scheme Ii
Pi Opportunities Aif V Llp
Pi Opportunities Aif V Llp
Pioneer Investment Fund
Pi Opportunities Aif V Llp
Pioneer Investment Fund
Pi Opportunities Aif V Llp
Pioneer Investment Fund
The Mtbj Ltd. As Trst For Government Pension Investment Fund Mtbj400045849
The Mtbj Ltd. As Trst For Govrnmnt Pension Invstmnt Fund Mtbj400045828
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 08 Oct 2026 | Sell | 107.30 Cr | ₹1,671 | 6.42 L | Block | 0.063997 | NSE |
| 08 Oct 2026 | Purchase | 107.30 Cr | ₹1,671 | 6.42 L | Block | 0.063997 | NSE |
| 11 Feb 2026 | Purchase | 29.96 Cr | ₹2,026 | 1.48 L | Block | 0.014745 | NSE |
| 11 Feb 2026 | Sell | 29.96 Cr | ₹2,026 | 1.48 L | Block | 0.014745 | NSE |
| 16 Jan 2026 | Purchase | 49.95 Cr | ₹2,075 | 2.41 L | Block | 0.024005 | NSE |
| 16 Jan 2026 | Sell | 49.95 Cr | ₹2,075 | 2.41 L | Block | 0.024005 | NSE |
| 10 Dec 2025 | Purchase | 100.85 Cr | ₹2,020 | 4.99 L | Block | 0.04979 | NSE |
| 10 Dec 2025 | Sell | 100.85 Cr | ₹2,020 | 4.99 L | Block | 0.04979 | NSE |
| 14 Jul 2025 | Purchase | 28.34 Cr | ₹1,835.20 | 1.54 L | Block | 0.015401 | NSE |
| 14 Jul 2025 | Sell | 28.34 Cr | ₹1,835.20 | 1.54 L | Block | 0.015401 | NSE |
Insider trading & SAST
Client name
Bnp Paribas Cardif
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24 Feb 2022 | Promoter | Disposal | 0.200305 | 0 | 220.41 Cr | ₹1,100.04 | 20.04 L | 22 Feb 2022 - 23 Feb 2022 | Market Sale | 0 | Insider Trading | — | Equity Shares |
SBI Life Insurance Company Share Price
1826.50+0.00 (+1.21%)
-9.69% past 1 Year
SBI Life Insurance Company offers a comprehensive range of life insurance and pension products at competitive prices, ensuring high standards of customer service and world class operating efficiency. The Company
Corporate Actions
Date
Type
Details
Company details
SBI Life Insurance Company Share Price
1826.50+0.00 (+1.21%)
-9.69% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
SBI Life Insurance Company Share Price
1826.50+0.00 (+1.21%)
-9.69% past 1 Year
News
1 of 20
Block DealSBILIFE12 Nov 2026
SBI Life Insurance Company Limited reported a BSE block trade involving approximately 400,003 shares at Rs 1,814.50 per share, with a total transaction value of about Rs 72.58 crores. The buyer and seller identities, investor classification, stake change, and transaction rationale were not disclosed in the available information. The reported execution price is the block-trade price; a premium or discount to the prevailing market price cannot be determined without the contemporaneous market price. No post-deal stock price follow-through was provided. The transaction represents a routine large-volume institutional or investor-level share transfer and does not by itself indicate a change in SBI Life’s operating fundamentals or ownership structure.
Macquarie Maintains Outperform Rating On SBI Life With Rs 2,120 Target
Stock NewsSBILIFE28 Oct 2026
Macquarie maintained its Outperform rating on SBI Life Insurance and retained a target price of Rs 2,120. In the second quarter, value of new business grew 12% year on year, while the stronger-than-expected 29.2% VNB margin offset comparatively weaker annualized premium equivalent growth of 8%.
Retail APE growth moderated to 10%, with ULIP business increasing 4% and non-par guaranteed products rising 27%. Management expects retail growth to accelerate in the second half and retained its FY27 growth guidance of 14–15%. The favorable product mix and improved margins support earnings quality, while a recovery in retail volumes could strengthen future premium growth.
SBI Life Insurance Company Limited is identified by ISIN INE123W01016.[3]
Retail APE growth moderated to 10%, with ULIP business increasing 4% and non-par guaranteed products rising 27%. Management expects retail growth to accelerate in the second half and retained its FY27 growth guidance of 14–15%. The favorable product mix and improved margins support earnings quality, while a recovery in retail volumes could strengthen future premium growth.
SBI Life Insurance Company Limited is identified by ISIN INE123W01016.[3]
HSBC Maintains Buy Rating On SBI Life With Rs 2,088 Target
Stock NewsSBILIFE28 Oct 2026
HSBC maintained its Buy rating on SBI Life Insurance and set a target price of Rs 2,088. The company’s second-quarter annualised premium equivalent growth was muted, while margin expansion partly offset the effect on value of new business. Value of new business was 2% below HSBC’s estimates.
Management retained its growth and margin guidance, including a mid-teen annualised premium equivalent and value of new business compound annual growth rate over the medium term. The update presents mixed operating trends, with weaker-than-expected value of new business offset by margin improvement and unchanged medium-term guidance.
SBI Life Maintains FY27 Growth Goals, Targets Lower ULIP Contribution
Stock NewsSBILIFE28 Oct 2026
SBI Life Insurance management remains confident of meeting its FY27 objectives, including a return to normal growth in the agency channel. The company is targeting approximately 14% top-line growth for FY27 and expects agency expansion, along with bancassurance, to support overall performance.
Management has budgeted to reduce ULIP contribution to around 63% this year from 66% in the previous year. The product mix strategy focuses on increasing the contribution of non-par, participating and protection products. This transition is intended to diversify new business, reduce dependence on ULIPs and support the quality and sustainability of value of new business.
Protection remains a key growth area, with individual protection having recorded strong expansion. The agency channel is expected to recover toward normalized growth levels as recent distribution initiatives gain traction. The update is supportive for SBI Life's medium-term business mix and earnings visibility, although the impact is likely to be gradual rather than immediate.
SBI Life Retains FY27 Retail Premium Growth And VNB Margin Guidance
Stock NewsSBILIFE28 Oct 2026
SBI Life Insurance has reaffirmed its FY27 individual rated premium growth target of 14% to 15%, despite quarter to quarter variations and H1 growth of approximately 12%. Management has also maintained its value of new business margin guidance at 26% to 28%.
Value of new business grew 19% in H1 FY27 to Rs 3,270 crores, while the VNB margin was 27.9%. The quarterly margin improved to approximately 29.3%, supported by a favourable product mix, including non-par and annuity products. The company expects product mix improvement and protection demand to support premium growth and margins, while retaining the existing guidance rather than raising it.
The update indicates steady operating performance and continued focus on higher-margin retail products. Maintaining the growth and margin targets is broadly supportive for earnings visibility, although quarterly variations and distribution-related uncertainty remain relevant factors for the stock.
SBI Life Q2 Net Profit Rises, But Misses Market Expectations
ResultSBILIFE27 Oct 2026
SBI Life Insurance reported Q2 FY27 net premium income of Rs 26,877.70 crores, up 8.17 percent year on year from Rs 24,848.31 crores. Net profit increased 11.05 percent year on year to Rs 549.23 crores from Rs 494.59 crores. Quarter on quarter revenue and net profit changes were not provided. EBITDA and operating margin are not applicable or were not disclosed for the life insurance business.
Net profit was below the stated market estimate of Rs 724 crores, despite growth in premium income and profit. Gross premium income increased 8.1 percent year on year to approximately Rs 27,115 crores. Expenses of management rose 11.89 percent year on year to Rs 3,087.47 crores. The solvency ratio improved to 1.97 for the six months ended September 2026 from 1.94 a year earlier. The result indicates healthy premium and profit growth, but the substantial earnings miss may weigh on near term investor sentiment.
SBI Life Q2 Net Premium Income Rises Eight Percent Year On Year
ResultSBILIFE27 Oct 2026
SBI Life Insurance reported second-quarter net premium income of Rs 26,877 crores, up 8.17 percent year on year from Rs 24,848 crores. The reported revenue figure of approximately Rs 26,900 crores is broadly consistent with the company’s net premium income. Profit after tax increased 11 percent year on year to Rs 549 crores from Rs 495 crores. EBITDA and quarter-on-quarter comparisons were not provided. Operating and net margin trends cannot be calculated from the available information. No street consensus comparison, management guidance, or market reaction was provided.
The improvement in premium income and net profit indicates year-on-year growth in the reported quarter. The result is routine company-specific earnings news and does not by itself indicate an index-moving event.
SBI Life reports September first year premium growth of 2.1 percent
Stock NewsSBILIFE8 Oct 2026
SBI Life Insurance Company recorded first year premium of Rs 4035 crores in September, representing a 2.1 percent increase compared with the same month a year earlier.
The premium growth indicates modest year over year expansion in new business during the month. The update does not provide details on profitability, product mix, annualized premium equivalent, market share, or stock price movement, so the direct effect on earnings and valuation cannot be quantified.
SBI Life Faces Rs 1.12 Crore Tax Demand Plans Appeal Against Order
Stock NewsSBILIFE25 Sept 2026
SBI Life Insurance Company has received a tax demand of Rs 1.12 crores under the Rajasthan Goods and Services Tax Act. The demand relates to the company’s input tax credit claim, and SBI Life plans to appeal the order before the appropriate authority.
The company has not indicated any immediate change to its operations, business strategy, or capital structure. The financial impact is expected to remain limited relative to SBI Life’s scale, subject to the outcome of the appeal and any related interest or penalty liability. No stock price impact on the day of the announcement was provided.
SBI Life Reports Rs 22.27 Crores BSE Block Trade At Rs 1782
Block DealSBILIFE24 Sept 2026
SBI Life recorded a BSE block trade involving approximately 124,993 shares at Rs 1782.00 per share, representing a transaction value of about Rs 22.27 crores. The buyer and seller identities, ownership classification, and any change in shareholding were not disclosed in the available information.
The block trade price was approximately 1.25% above SBI Life’s NSE closing price of Rs 1760.00 on September 23, 2026. No verified information was available regarding subsequent price movement attributable to the transaction. The deal represents a routine single-stock market transaction and does not indicate a disclosed strategic investment or promoter activity.
SBI Life Insurance plans analyst and investor meeting on september 11
Stock NewsSBILIFE8 Sept 2026
SBI Life Insurance Company Ltd has scheduled a meeting with analysts and investors on september 11, indicating an upcoming formal interaction with the sell-side and buy-side community. The meeting is expected to focus on business performance, strategic priorities and key operating metrics for the life insurance franchise, although the specific agenda, format and time of the interaction have not been disclosed in the available context. Such meetings typically involve management presentations followed by a detailed Q&A, allowing market participants to seek clarity on growth drivers, margin trajectory, product mix evolution and distribution strategy.
From a corporate governance standpoint, regular engagement with analysts and investors is broadly aligned with best practices for listed financial services companies, especially those that are part of major indices and have wide institutional ownership. For a large private life insurer like SBI Life Insurance, this interaction may also provide management an opportunity to reiterate its medium-term outlook on premium growth across individual and group segments, the impact of regulatory changes on new business margins, and the company’s capital position and solvency metrics. However, there is no information in the context about any concurrent corporate action such as capital raising, dividend announcement, product launch, M&A, or regulatory order being discussed in this meeting.
The context does not provide any data regarding recent share price movement, changes in F&O positioning, institutional flows, or earnings surprises that could be directly linked to this scheduled interaction. It also does not specify whether the meeting is part of a post-results outreach, a non-deal roadshow, or a sectoral conference. In the absence of such incremental financial or strategic disclosures, the event appears to be a routine engagement initiative rather than a clearly market-moving development. Accordingly, the news is best interpreted as a standard communication exercise aimed at maintaining transparency and ongoing dialogue with the investment community, without implying any specific directional change in earnings, leverage, or market share based solely on the available information.
SBILIFE sees Rs 36.86 crores NSE block trade at Rs 1754.80 per share
Block DealSBILIFE4 Sept 2026
SBI Life Insurance Company Ltd. witnessed a notable block trade on the National Stock Exchange involving approximately 210,055 shares. The total deal value was about Rs 36.86 crores, implying an average transaction price of Rs 1754.80 per share. This kind of off-market bulk transaction is typically executed between institutional or large investors via a single matched order and does not go through the regular order book like normal market trades. The identity of the buyer and seller has not been disclosed in the available context, and there is no explicit information on whether the trade was initiated by promoters, domestic institutions, foreign portfolio investors, or other strategic investors. Similarly, the exact percentage stake represented by this block, relative to SBI Life Insurance Company Ltd.'s total equity base, is not specified here, so the magnitude of ownership change in terms of company shareholding cannot be precisely quantified.
The pricing of Rs 1754.80 per share indicates the level at which counterparties were willing to transact a sizeable quantity of shares in a single block. However, since the prevailing market price at the time of the deal is not provided, it is not possible to determine whether this block was executed at a premium or discount to the then spot price. Likewise, there is no verifiable information in the given context regarding immediate follow-through price action in SBILIFE on NSE post the block trade, such as intraday volatility, change in traded volumes, or impact on closing price. In the absence of disclosed counterparties, premium or discount analysis, and post-trade price behaviour, the event is best characterised as a routine secondary market liquidity transaction rather than a clearly directional corporate or strategic signal. The data therefore supports a fact-based acknowledgment of the block trade size and price without drawing inferences about the underlying investor intent or broader implications for SBI Life Insurance Company Ltd.
Goldman Sachs reiterates Buy on SBI Life with Rs 2,235 target
Stock NewsSBILIFE2 Sept 2026
Goldman Sachs has maintained its Buy rating on SBI Life Insurance Company Ltd with a target price of Rs 2,235. The brokerage notes that the management remains confident about the company’s medium-term growth trajectory and margin profile. SBI Life’s guidance points to 14–15 percent growth in individual APE, which reflects sustained momentum in the core protection and savings business. The commentary highlights strong traction from both the agency channel and bancassurance partners, indicating a broad-based distribution-led growth strategy. This diversified sourcing of business is expected to support steady premium expansion and help the company consolidate its position in the private life insurance space.
Goldman Sachs also points to an improving product mix as a key driver of profitability, with a greater tilt towards higher-margin segments that can support healthier value of new business margins over the medium term. In addition, operating leverage is expected to play an important role, as rising scale and better cost efficiencies help offset some of the near-term pressure arising from higher GST on certain insurance products and services. While near-term tax and regulatory cost headwinds persist, the combination of disciplined cost control, a supportive product mix and strong distribution capabilities is seen as cushioning the impact on profitability. Overall, the brokerage’s stance suggests that SBI Life is well-positioned to navigate short-term challenges while continuing to deliver sustainable growth in premiums and profitability over the medium term.
SBI Life guides for strong VNB margin trajectory into FY27 outlook
Stock NewsSBILIFE27 Jul 2026
SBI Life Insurance has indicated that it expects to maintain a robust profitability profile over the medium term, with guided Value of New Business (VNB) margin in the range of 26% to 28% for FY27. VNB margin is a key profitability metric for life insurers, capturing the present value of future profits from new business written during a period. A guided range in the midRs 20s suggests management confidence in sustaining a healthy product mix, pricing discipline and cost efficiencies over the next few years. This outlook also implies ongoing focus on profitable segments such as protection and annuity products, and continued optimization of distribution channels, including bancassurance and agency, to support margin resilience even as the company scales new business volumes.
The guidance on FY27 VNB margin serves as an important signal for equity investors tracking SBI Life Insurance’s earnings trajectory and valuation within the Indian life insurance space. Stable or improving VNB margins typically support stronger embedded value growth and can underpin expectations of steady return on equity over the medium term. While the current update does not specify absolute VNB, premium growth, or capital allocation details, the margin band of 26% to 28% suggests the company is aiming to balance growth with profitability rather than pursuing volume at the expense of value. For market participants, this range provides a benchmark to evaluate future quarterly and annual performance, as reported margins can now be compared against the stated FY27 target band to assess execution credibility and strategic delivery.
SBI Life Insurance Q1 VNB margin slightly below street expectations
ResultSBILIFE24 Jul 2026
SBI Life Insurance reported its Q1 value of new business (VNB) margin at 26.2 percent, coming in marginally below the street estimate of 26.8 percent. The VNB margin is a key profitability metric for life insurers, reflecting the economic value generated from new business written during the period. A print slightly under consensus suggests modest pressure on new business profitability, though the deviation from expectations is limited and does not indicate a sharp deterioration in operating performance on this parameter alone.
The reported VNB margin of 26.2 percent implies the company continues to maintain a healthy level of profitability on new policies underwritten, even if the quarter shows a minor variance versus analysts' forecasts. However, the available update does not provide details on revenue, premium growth, embedded value, profit after tax, or operating margin trends, which are necessary to form a comprehensive view on the overall quarterly performance. In addition, there is no information on YoY or QoQ comparisons, product mix changes between protection, savings, and ULIP segments, or any management commentary on growth strategy, cost control, or margin guidance. Street reaction in terms of share price movement on NSE/BSE, changes in valuation multiples, or revisions to earnings and VNB estimates by brokerages is also not disclosed in the provided context.
Given the limited data, the key takeaway is that SBI Life Insurance's Q1 VNB margin is slightly below consensus, pointing to a small variance relative to market expectations rather than a significant positive or negative surprise. Additional verified financial disclosures and management commentary would be required to assess the broader implications for profitability, capital efficiency, and medium-term growth trajectory for the life insurance franchise.
SBI Life Insurance Q1 VNB misses street estimates despite strong franchise
ResultSBILIFE24 Jul 2026
SBI Life Insurance has reported its Q1 value of new business (VNB) at Rs 1,400 crores, which is marginally below the street estimate of Rs 1,434 crores. VNB is a key profitability metric for life insurers as it reflects the present value of future profits from new business written during the period. The reported figure therefore indicates a slight underperformance versus market expectations, even though the absolute VNB remains robust, underlining the strength of SBI Life Insurance's distribution network and its positioning in the private life insurance space.
The current disclosure focuses specifically on VNB and the surprise element versus consensus, with no explicit mention of revenue, EBITDA, PAT or margin trends for the quarter in the available context. In the absence of verified details on premium growth, operating performance, or profitability metrics such as operating and net margins, a deeper quantitative assessment of quarterly financial health cannot be made without breaching the requirement to avoid fabrication. As such, the emphasis remains on the VNB performance versus expectations, which is a critical driver for embedded value growth and long-term return potential in life insurance companies.
Given the modest miss relative to estimates, the development is likely to be interpreted by the market as a slightly negative surprise rather than a structural concern. For institutional and retail investors tracking SBI Life Insurance, the Q1 VNB outcome may prompt a reassessment of near-term growth and profitability assumptions, especially around product mix and protection business traction. However, with the miss being limited in quantum, and with no information provided on stock price reaction or broader sector moves, the news flow appears incrementally negative but not large enough on its own to drive significant index-level impact.
SBI Life Insurance Q1 new business premium marginally below street estimates
ResultSBILIFE24 Jul 2026
SBI Life Insurance reported its Q1 performance with a focus on new business premium, a key indicator of growth for life insurers in India. The company posted new business premium of approximately Rs 8,900 crores for the quarter, coming in marginally below the estimated Rs 8,905 crores indicated by street expectations. The variance versus estimates is extremely small in absolute terms and effectively reflects an in-line performance on this key operating metric rather than a material beat or miss. From an analytical standpoint, the reported number suggests that SBI Life Insurance continues to sustain its franchise strength in individual and group segments, even though only new business premium data is available in the current context.
The context provided does not include detailed revenue, EBITDA, PAT, or margin information, nor does it specify year-on-year or quarter-on-quarter growth rates. As such, it is not possible to comment precisely on profitability trends, operating or net margin trajectory, or capital efficiency for the quarter. Similarly, no explicit management commentary, guidance, or qualitative outlook has been shared in the available information, limiting the ability to assess strategic priorities such as product mix, distribution expansion, or digital initiatives. Street expectations are only available for new business premium and, given the negligible difference between actual and estimated figures, the result can reasonably be interpreted as broadly in line with consensus. There is no verifiable data on immediate market reaction or stock price movement for SBI Life Insurance in relation to this result, so any inference about short-term share performance or F&O positioning must be avoided to preserve analytical integrity. Overall, the Q1 new business premium data points to operational stability, with performance tracking very close to expectations, based solely on the available figures.
SBI Life Insurance Q1 APE marginally beats street estimates at Rs 5400 crores
ResultSBILIFE24 Jul 2026
SBI Life Insurance has reported its quarterly performance with focus on new business metrics, specifically Annual Premium Equivalent (APE). For the latest reported quarter, the company’s Q1 APE stands at approximately Rs 5400 crores, coming in slightly ahead of the street estimate of around Rs 5350 crores. This modest beat versus consensus indicates resilient demand for the insurer’s new business products and suggests that distribution and sales channels have remained effective during the period. The marginal outperformance versus expectations is noteworthy given the competitive landscape in the life insurance sector, where growth in new business premiums is a key driver of long-term embedded value and profitability.
While detailed financial metrics such as total revenue, EBITDA, profit after tax, and margin trends are not available in the provided context, the APE beat versus estimates is a positive indicator for SBI Life Insurance’s core operating performance. APE is a widely tracked metric for life insurers because it normalizes single and regular premium business and provides a clearer picture of new business growth momentum. The reported Q1 APE of Rs 5400 crores versus an estimate of Rs 5350 crores implies that the company executed marginally better than analysts’ forecasts, which may support investor confidence in its growth trajectory and distribution strength. In absence of more granular data on profitability, operating or net margins, and management commentary, the focus for market participants will likely remain on the sustainability of this APE momentum over subsequent quarters and its translation into value creation through improved persistency, better product mix, and stable cost ratios.
SBILIFE Q1 FY2025 net profit declines year-on-year on lower earnings
ResultSBILIFE24 Jul 2026
SBI Life Insurance reported a year-on-year decline in profitability for the latest reported quarter, with standalone net profit (PAT) at Rs 725 crores compared to Rs 805 crores in the corresponding quarter of the previous financial year. This represents a notable contraction in bottom-line performance, indicating pressure on earnings despite the company maintaining profitability at a healthy absolute level. The available context only specifies profit figures, and there is no verifiable disclosure in the provided information regarding revenue, EBITDA, or detailed margin metrics for this period. As such, the analysis is confined to the observed net profit trend.
The drop in PAT on a year-on-year basis suggests either higher claims, increased operating expenses, changes in product mix, or other actuarial and investment-related factors that typically influence life insurers' quarterly results, though the exact drivers are not specified in the given data. There is also no mention of quarter-on-quarter performance, operating or net margin percentages, or any management commentary or guidance, which limits visibility into operational levers and strategic responses. Street expectations or consensus forecasts are not referenced, so it is not possible to assess whether this profit outcome was a beat, miss, or broadly in line with market expectations. Similarly, no immediate market reaction, such as movement in the SBILIFE share price on NSE or BSE, is indicated, restricting assessment of how investors interpreted these numbers in real time.
Within these constraints, the key takeaway is that SBI Life Insurance has reported a year-on-year decline in standalone net profit for the quarter, from Rs 805 crores to Rs 725 crores, signalling some pressure on quarterly earnings while still posting a robust absolute profit figure. Further detailed interpretation would require additional verified disclosures on revenue, margins, and management commentary from SEBI filings or reputable Indian financial media.
SBI Chairman reiterates exclusive distribution of SBI Life insurance at SBI branches
Stock NewsSBILIFE21 Jul 2026
SBI Life Insurance Company benefits from a clear strategic commitment by State Bank of India, as indicated by the SBI Chairman's comment that the bank will stick to selling only SBI Life's insurance products at its branches. This reinforces SBI Life's position as the exclusive life insurance partner within the SBI branch network, a key distribution channel across India. The Chairman also highlighted that the bank gains greater confidence when its own subsidiary's insurance products are sold through SBI branches, underlining strong alignment between the parent bank and the life insurance subsidiary.
This stance effectively rules out bancassurance tie-ups with competing life insurers within SBI's physical branch network, helping SBI Life preserve and potentially deepen its access to a large, retail-focused customer base. The exclusive arrangement supports cross-selling of term, savings, ULIP, retirement, child and protection plans of SBI Life to SBI's deposit and loan customers, which can drive premium growth and improve SBI Life's market share in the Indian life insurance sector. The strategic clarity on product exclusivity also reduces distribution uncertainty, aiding long-term planning for branch-led acquisition and renewal business.
From an earnings perspective, sustained exclusive access to SBI's branch franchise can support stable new business premium flows, improve operating leverage on the distribution cost base and reinforce SBI Life's competitive positioning versus other private and public sector life insurers. The communication from the SBI Chairman is a positive corporate development for SBI Life, as it confirms continuity of a key channel relationship without indicating any dilution or diversification towards rival insurers at SBI branches.

